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Abstract

Pituitary adenylyl cyclase-activating polypeptide (PACAP) is a small pleiotropic
neuropeptide found throughout the central and peripheral nervous system. It binds with highest
affinity to its complementary receptor, pituitary adenylyl cyclase-activating polypeptide receptor
1. Using PACAP-Cre transgenic mice, an adeno-assisted viral construct was injected into the
diencephalon for Cre-dependent expression of mCherry fluorescent protein in PACAPexpressing neurons. We observed red mCherry fluorescence in PACAP expressing neurons in
the suprageniculate (SG) thalamic nucleus, a component of the auditory sensory pathway. The
nucleus receives afferent fibers from the deep layers of the superior colliculus (SC) and sends
axonal projections to various targets including the auditory cortex and posterior parietal cortex.
Previous studies in hippocampal and limbic systems have shown that PACAP is co-expressed in
glutamatergic neurons. In coherence, inspection of Allen’s Brain Atlas for vesicular glutamate
transporter (VGLUT) and glutamic acid decarboxylase (GAD) transcript expression, as markers
for glutamate and GABA neurons, respectively, suggests that the PACAP expressing neurons are
glutamatergic in nature. The findings of this study are novel in identifying PACAP expression in
an auditory relay nucleus.
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Introduction

Background:
PACAP is a neuroendocrine peptide encoded by the gene ADCYAP1 (Hosoya et al.,
1992). It was first isolated, as a chain of 38 and 27 amino acids, denoted as PACAP-38 and
PACAP-27 respectively, from the ovine hypothalamus based on its abilities to stimulate cAMP
production in anterior pituitary cells (Miyata et al., 1989). The effects of PACAP are pleiotropic;
a significant amount of literature exists on its involvement in homeostatic functions, stress
circuitry, and neuromodulation of glutamate circuitry (Hammack et al., 2009; Huang, Waters, &
Machaalani, 2017; Stella & Magistretti, 1996).
PACAP is part of a superfamily of structurally related peptides that includes vasoactive
intestinal peptide (VIP), glucagon, secretin, gastric inhibitory peptide, and growth hormonereleasing hormone (Harmar et al., 1998). Within the glucagon/secretin family, receptors and
ligands exhibit a high degree of sequence homology. As reviewed by Laburthe, Couvineau, and
Tan (2007), VIP and PACAP are structurally related neuropeptides with PACAP sharing 68% of
its sequence identity with VIP. The PACAP receptor also shares some amino acid and structural
similarities with other related Class B G protein coupled receptors (GPCRs), including secretin
and glucagon receptors. Similar to other Class B receptors and unlike Class A GPCRs the PAC1
receptor has a large N-terminal extracellular domain for high affinity ligand binding (Laburthe et
al., 1996).
Three G protein-coupled receptors, VPAC1, VPAC2, and PAC1 have been identified to
bind to PACAP. PACAP binds exclusively to the PAC1 receptor while VIP and PACAP have
near equal high affinity for the VPAC1 and VPAC2 receptors (Harmar et al., 2012). The PAC1
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receptor is highly abundant in neuroendocrine tissues such as the brain, pituitary system, and
adrenal glands. The two VPAC receptors are expressed in the nervous system but mainly
concentrated in peripheral tissues including lung, liver, and testis (Vaudry et al., 2009). These
receptors utilize a variety of second messenger cascades to activate cellular pathways; in the case
of PAC1, the pathway is linked predominantly to adenylyl cyclase and phospholipase C
activities.
PACAP acts in diverse pathways and is essential for postnatal survival. A study by Gray,
Cummings, Jirik, and Sherwood, (2001) showed that PACAP-knockout mice experienced an
80% mortality rate in the first three postnatal weeks. The authors findings suggest that this is
due to a disruption in PACAP’s normal role as a regulator of lipid and carbohydrate metabolism.
PACAP functions in many roles throughout the nervous system, one of which is in the auditory
system.

Suprageniculate Nucleus:
The suprageniculate (SG) nucleus is a thalamic relay center found dorsal to the medial
geniculate nucleus (MGN). From a rostral viewpoint, the SG appears between the
lateroposterior nuclear complex and the principal pretectal nucleus (Figure 1). The majority of
the SG is superior to the posterior thalamic nucleus (Neylon & Haight, 1983). In the possum, the
SG receives a strong input from the superior colliculus (SC), likely from the deep layers. SG
cortical projection neurons have been shown to respond to visual, somatosensory, and auditory
stimulation in placental mammals as well, such as in cats and monkeys (Loe & Benevento, 1969;
Sudakov, MacLean, Reeves, & Marino, 1971). Considering these observations, it is likely that
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the SG serves as a relay for multimodal sensory projections originating from the deep layers of
the SC and projecting to their respective cortical regions: visual, auditory, and somatosensory.
Visual stimulation has been observed to play an important role in affecting auditory
perception, including the spatial localization of sounds (Howard & Templeton, 1966; Recanzone,
2003). This type of multimodal processing has been shown in visual-auditory interactions in the
primary auditory cortex (Kayser, Petkov, & Logothetis, 2008). These findings contribute to a
body of evidence that suggests visual information is being projected to the auditory cortex,
subsequently affecting processing of auditory stimuli. Although the visual cortex does project
directly to the auditory cortex (Bizley, Nodal, Bajo, Nelken, & King, 2007), a second major
source of visual input stems from the SG (Smith, Manning, & Uhlrich, 2010).
Despite innervation from a visual relay center, it has been established that SG neurons in
many mammals (such as cats) are primarily projecting to the auditory cortex (Benedek, Pereny,
Kovacs, FischerSzatmari, & Katoh, 1997; Paroczy et al., 2006). A robust innervation from SC
layers to the SG is also present in rats (Linke, 1999). Recent research has shown that rat SG
cells then project to the auditory cortex, in particular layers I, V, and VI (Smith, Manning, &
Uhlrich, 2010). These results also show that SG axons are capable of innervating multiple
cortical layers and may extend a considerable distance in layer I. Importantly, researchers also
found that these projections were non-GABAergic: meaning they are putatively glutamatergic.

Auditory Pathway:
The central auditory pathway begins with the ear. Auditory information is processed and
transduced by specialized inner ear hair cells; the signals are then relayed to the central auditory
pathway by the vestibulocochlear nerve. The vestibulocochlear nerve transmits afferent auditory
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information to the cochlear nuclei. Here, the auditory information splits; one pathway relays to
the reticular formation, while the primary auditory pathway relays auditory information to the
superior olivary nuclei. Information is then relayed to the inferior colliculus (IC). The IC then
relays the auditory information through the brachium of the inferior colliculus to several
thalamic nuclei, especially MGN. From the thalamus, all auditory information is sent to the
primary auditory cortices for conscious processing (Webster & Fay, 2013).
The auditory cortex (AC) is located in the cerebrum and modulates attentional focus of
the auditory pathway. The AC sends descending projections down to brainstem nuclei to
regulate auditory input and adapt to spatial cues (Mellott, Bickford, & Schofield, 2014). The
descending corticofugal projections from the AC can terminate onto the MGN or the IC. They
also project down to the nucleus of the brachium of the inferior colliculus.
Hannibal (2002) found immunohistochemical evidence for PACAP expression in several
regions of the auditory pathway, including the cochlear and vestibular nuclei. PACAP
expression was also found in cranial nerve VIII, the vestibulocochlear nerve. Kawano et al.,
(2001) demonstrated that PACAP is present in the cochlea of rats. In situ hybridization showed
that components of the stria vascularis, spiral ganglion and marginal cells, expressed mRNA for
PACAP. Additionally, PACAP is thought to act within the organ of Corti as a neuromodulator of
afferent projections; it may also play a role in protection from excitotoxicity (Drescher et al.,
2006). Furthermore, the Allen Brain Atlas has shown that several thalamic nuclei that are
involved in sensory processing demonstrate PACAP expression; notably, these include the MGN
and SG.

PACAP Modulates Glutamate Receptor Function:
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Chen, Buchanan, Ding, Hannibal and Gillette (1999) were among the first to show that
PACAP plays an important role in modulating glutamate activity. Chen et al., (1999) focused
specifically on PACAP’s role controlling circadian activity phase shifts in the
retinohypothalamic tract (RHT). They were able to demonstrate that PACAP receptor-mediated
processes can alter glutamate-generated phase shifts and amplitudes of circadian behavioral
responses.
Hannibal, Moller, Ottersen and Fahrenkrug (2000) showed that all PACAP expressing
retinal ganglion cells were co-localized with glutamate. The postulated role of PACAP in the
RHT is to assist in the stimulation of the suprachiasmatic nucleus (SCN), which is primarily
responsible for generating circadian rhythms.
Michel, Itri, Han, Gniotczynski, and Colwell (2006) showed that PACAP is a strong
modulator of glutamate activity in the SCN, especially during the early phase of subjective night.
PACAP accomplishes this modulation by enhancing the evoked currents of both NMDA
receptors (NMDAR) and AMPA receptors (AMPAR) in SCN neurons. Evidence generated by
this study suggested that the magnitude of AMPA currents is dependent on PAC1 receptormediated processes, in particular, the adenylyl cyclase/cAMP-signaling cascade. These changes
in synaptic strength have been shown to occur via PKA mediated phosphorylation of AMPARs
(Toda & Huganir, 2015).
Further evidence of PACAP’s ability to modulate glutamate signaling has been found in
the hippocampus, where it modulates NMDARs and AMPARs. In hippocampal CA1 pyramidal
neurons, PACAP modulates AMPA receptor-mediated currents via PAC1 and VPAC2 receptors.
Both of these pathways use cAMP/PKA cascades to affect change (Costa, Santangelo, Volsi, &
Ciranna, 2009). Costa et al., (2009) found that PACAP altered glutamate-induced signaling in
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AMPARs by reducing the amplitude and duration of generated EPSCs via VPAC2 receptors.
When PKA was inhibited, the effect of PACAP was strongly reduced, suggesting that PACAP’s
effects on these neurons are primarily postsynaptic.
Macdonald et al., (2005) demonstrated that PACAP can enhance NMDA receptormediated transmission on CA1 pyramidal neurons, primarily via PAC1 receptors. Researchers
administrated PACAP38 to the hippocampus; CA3 neurons were then found to have increased
levels of Schaffer collaterals EPSCs. PACAP38 also caused an increase of peak NMDAR
currents in CA1 neurons.
Although few studies have shown evidence of PACAP-mediated influence of AMPA
currents, a growing line of evidence suggests that NMDA receptors are influenced by PACAP in
many brain regions such as the SCN (Michel et al., 2006), hippocampus (Macdonald et al., 2005)
and cerebellar regions (Llansola, Sanchez-Perez, Montoliu, & Felipo, 2004). These studies in
aggregate demonstrate the differential effects of PACAP on NMDA and AMPA receptors via
PAC1 or VPAC2 receptors. The purpose of the study herein is to identify where PACAP
activity is occurring in the diencephalic region of the mouse brain and whether it contributes to
auditory-sensory pathways.

Materials and Methods

Surgery:
PACAP-Cre transgenic mice were received from Bradford Lowell (McLean Hospital,
Tufts University; Krashes et al., 2014). PACAP-Cre littermate (n=3; 6 weeks of age) mice were
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thoroughly anesthetized with isoflurane (3-4%) before the surgical delivery of adeno-associated
virus (AAV) vector (AAV-EF1a-DIO-mCherry) for Cre-dependent expression of the fluorescent
tracer mCherry. Mice were secured in place using stereotaxic equipment, an incision was then
made along the sagittal surface of the scalp. A small hole was drilled at the coordinates in mm
from Bregma, AP -3.28, ML 1.75, and DV -2.75 from the surface of the dura. A 1 μL Hamilton
syringe was then used to deliver 0.5μL of AAV. The incision was then closed and the mouse
was allowed a week to recover.

Perfusion:
Mice were euthanized via perfusion. Each mouse was anesthetized with isoflurane; an
incision was then made beneath the rib cage of the animal. The fascia tissue surrounding the
heart was opened, a butterfly needle was then inserted into the left ventricle. Saline was injected
into the left ventricle as an incision was made simultaneously in the right atrium. Once the saline
flush was completed, the syringe was replaced with paraformaldehyde (4%) for perfusion
fixation. The cranium was opened along the suture lines and the brain was removed.

Fixation, cryosectioning and microscopy:
The brain was placed in a fixative solution (4% paraformaldehyde) for 24 hours. To
ensure cryoprotection, the brain was then placed in three consecutive sucrose solutions, 10%,
20%, and 30% respectively, for 24 hours each. Once the brain was fully saturated, it was
removed and frozen using Tissue-Tek O.C.T. compound cryostat gel and dry ice. The brain was
then sliced on a Cryostat machine at a thickness of 40 μm. Brain slices were mounted on
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microscope slides directly after slicing. Slides were observed and micrographed using an
epifluorescent microscope with Cy3 or Texas Red filter sets.

Results

Microinfusion of the AAV-EF1a-DIO-mCherry vector into the diencephalon of the
PACAP-Cre mice allowed the Cre-dependent expression of the fluorescent mCherry protein in
PACAP-expressing neurons. One week after infusions, the brains were harvested and prepared
as described in Methods; they were then cryosectioned and inspected on a fluorescent
microscope for mCherry expression. From adjacent sections, robust mCherry fluorescence was
observed in isolated PACAP neurons in the suprageniculate thalamic nucleus (Figure 2A – 2F).
The expression was compact and discrete; the right hand panels are higher magnifications of the
expression sites to better illustrate the labeling. The mCherry signal was cytoplasmic and
extended into a few processes and as the labeled process could not be traced for any significant
length, it is unclear if these are PACAP projection neurons or interneurons in the circuit. These
data correlated well with the mouse brain PACAP mRNA in situ hybridization data in the Allen
Brain Atlas demonstrating PACAP transcript expression in the same suprageniculate nucleus
(Figure 3, circumscribed area). Not shown by our vector injections but illustrated in the Atlas,
the ventral medial geniculate (MGV) nucleus may also contain PACAP expressing neurons;
notably, PACAP expression is not evident in dorsal medial geniculate (MGD) nucleus from the
Atlas or by our injections.
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For many of the central PACAP neurocircuits examined to date PACAP is localized
predominantly to glutamatergic neurons. Although time restrictions did not allow us to
immunocytochemically process the mCherry-labeled sections for glutamatergic and GABAergic
markers, inspection of VGLUT1/VGLUT2 and GAD transcript expression patterns in the Allen
Brain Atlas revealed that the expression of excitatory or inhibitory neuronal transcripts in the
suprageniculate nucleus appears unique (Figure 4, circumscribed area). The suprageniculate
nucleus does not appear to express VGLUT1, but robustly expresses VGLUT2; the expression of
GAD transcripts does not appear to coincide with those for PACAP-mCherry. Considering the
similarities with VGLUT2 transcript localization patterns, the PACAP expressing neurons in the
suprageniculate nucleus appear glutamatergic in nature and coincide with PACAP mechanisms
in other neuronal systems.

Discussion

By using PACAP-Cre transgenic mice, we observed PACAP activity in the SG thalamic
nucleus. The SG receives inputs from the deep layers of the SC and projects to the auditory
cortex and posterior parietal cortex. Smith, Manning, and Uhlrich (2010) have shown that cells
in the SG project to layers I, V, and VI of the auditory cortex; they also demonstrated that these
projections were non-GABAergic. Drawing from results found in the Allen Brain Atlas, these
projections are putatively glutamatergic.
The VGLUT2 glutamate transporter protein was found in particular abundance around
the region of the SG. The GABA synthesis enzyme, GAD, and glutamate transporter, VGLUT1,
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were both found in significantly lower concentrations in this region. The Atlas illustrated that
the MGV also contains PACAP expressing neurons, although neither the Atlas, nor our
injections showed PACAP expression in the MGD.
The MGV and MGD are non-GABAergic thalamocortical relay centers in the auditory
pathway which receive projections from the IC. The MGV and MGD project primarily to layers
III and IV of the auditory cortex (Smith, Uhlrich, Manning, & Banks, 2012). Interestingly, the
SG terminates primarily in layers I, V, and VI (Smith, Manning, & Uhlrich, 2010), suggesting
that the MGV and MGD are acting in a different circuit than the SG. Smith, Uhlrich, Manning,
and Banks (2012) found that MGD terminals in the auditory cortex are larger than those of the
MGV and synapse more frequently in the posterodorsal (PD) region of the cortex. Kimura et al.,
(2010) have postulated that the MGD projections to the PD region of the cortex are involved in
spatial processing of auditory information. Presently, it is unclear why PACAP transcripts are
found in MGV but absent in the MGD, particularly because, like the SG, the MGD is involved in
auditory spatial processing. Differences in PACAP expression may be due to evolutionary
divergence of communication in auditory pathways. The roles of PACAP in these pathways are
novel but require additional investigation.
Considering the results of our study and the Atlas, it is likely that PACAP and glutamate
are colocalized in the SG. Here PACAP may play a modulatory role in glutamate signaling.
PACAP has been shown to modulate glutamate signaling via AMPA in the SCN (Michel et al.,
2006) and NMDA receptors in hippocampal CA3 and CA1 neurons (Macdonald et al., 2005).
The presence of PACAP in the SG suggests a role in glutamate modulation.
To date, the role of NMDA receptors in glutamate modulation appears to be particularly
promising. PACAP acts in various, conflicting roles and exhibits the ability to both reduce or
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enhance EPSCs in the hippocampus (Costa et al., 2009; Macdonald et al., 2005). PACAP has
been shown to act as an inhibitory (Kondo et al., 1997), excitatory (Roberto and Brunelli, 2000)
and biphasic (Roberto et al., 2001) modulator of synaptic transmission in CA1 neurons. The
opposing roles of PACAP demonstrated in these studies may be due to differing concentrations
of PACAP at the active site or the research techniques used.
Findings from PACAP activity in the hippocampus suggest that PACAP acts primarily as
a post-synaptic modifier of glutamate transmission. Ciranna and Cavallaro (2003) demonstrated
that in the presence of the PKA-inhibitor cAMPS-Rp, PACAP-containing cells showed
significantly lower amplitude EPSCs in CA1 neurons. The PACAP activity that is not inhibited
by administration of cAMPS-Rp may be acting at a presynaptic site. This line of evidence is
supported by Otto, Zuschratter, Gass and Schutz (1999) whose immunohistochemical analysis
localized PACAP activity around synaptic vesicles in the CA3 region.
PACAP’s activity at the postsynaptic site is likely occurring at PAC1 and VPAC2
receptors (Costa et al., 2009). After the PACAP ligand binds, it has been suggested that the
PKA-mediated signaling cascade releases the RACK1 scaffolding protein from Fyn and the
NR2B subunit of the NMDA receptor (Yaka, He, Phamluong, & Ron, 2003). This step allows
Fyn to phosphorylate NR2B which then results in an increase of EPSCs through the NMDA
channel. This mechanism provides a putative explanation for PACAP’s ability to modulate CA1
neurons in an excitatory fashion.
Given the high conservation of pharmacological processes, it is likely that PACAP
activity in the SG is acting in a similar way to that of the hippocampus. In the SG, PACAP could
play a diverse cast of roles in altering rates of synaptic transmission. This would mean that
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PACAP activity in the SG assists in fine tuning response spatial localization of sounds, response
orientation, auditory focus, multimodal processing and other functions.
The exact physiological role of PACAP in the SG is still unknown. Current literature
suggests that PACAP activity in the SG may be modulating glutamate activity via NMDA or/and
AMPA receptors, in an excitatory, inhibitory, or biphasic manner. Future studies investigating
the colocalization of PACAP and glutamate in the SG nucleus of the thalamus will help to clarify
this question.

PACAP EXPRESSION IN AN AUDITORY NEUROCIRCUIT

15

References

Allen Brain Atlas: Mouse Brain. http://mouse.brain-map.org
Benedek, G., Pereny, J., Kovacs, G., FischerSzatmari, L., & Katoh, Y. Y. (1997). Visual,
somatosensory, auditory and nociceptive modality properties in the feline suprageniculate
nucleus. Neuroscience, 78(1), 179-189. doi:Doi 10.1016/S0306-4522(96)00562-3
Bizley, J. K., Nodal, F. R., Bajo, V. M., Nelken, I., & King, A. J. (2007). Physiological and
anatomical evidence for multisensory interactions in auditory cortex. Cerebral Cortex,
17(9), 2172-2189. doi:10.1093/cercor/bhl128
Casseday, J. H., Kobler, J. B., Isbey, S. F., & Covey, E. (1989). Central acoustic tract in an
echolocating bat: an extralemniscal auditory pathway to the thalamus. J Comp Neurol,
287(2), 247-259. doi:10.1002/cne.902870208
Chen, D., Buchanan, G. F., Ding, J. M., Hannibal, J., & Gillette, M. U. (1999). Pituitary adenylyl
cyclase-activating peptide: a pivotal modulator of glutamatergic regulation of the
suprachiasmatic circadian clock. Proc Natl Acad Sci U S A, 96(23), 13468-13473.
Ciranna, L., & Cavallaro, S. (2003). Opposing effects by pituitary adenylate cyclase-activating
polypeptide and vasoactive intestinal peptide on hippocampal synaptic transmission.
Experimental Neurology, 184(2), 778-784. doi:10.1016/S0014-4886(03)00300-5
Costa, L., Santangelo, F., Li Volsi, G., & Ciranna, L. (2009). Modulation of AMPA receptormediated ion current by pituitary adenylate cyclase-activating polypeptide (PACAP) in
CA1 pyramidal neurons from rat hippocampus. Hippocampus, 19(1), 99-109.
doi:10.1002/hipo.20488

PACAP EXPRESSION IN AN AUDITORY NEUROCIRCUIT

16

Drescher, M. J., Drescher, D. G., Khan, K. M., Hatfield, J. S., Ramakrishnan, N. A., AbuHamdan, M. D., & Lemonnier, L. A. (2006). Pituitary adenylyl cyclase-activating
polypeptide (PACAP) and its receptor (PAC1-R) are positioned to modulate afferent
signaling in the cochlea. Neuroscience, 142(1), 139-164.
doi:10.1016/j.neuroscience.2006.05.065
Gray, S. L., Cummings, K. J., Jirik, F. R., & Sherwood, N. M. (2001). Targeted disruption of the
pituitary adenylate cyclase-activating polypeptide gene results in early postnatal death
associated with dysfunction of lipid and carbohydrate metabolism. Mol Endocrinol,
15(10), 1739-1747. doi:10.1210/mend.15.10.0705
Hammack, S. E., Cheung, J., Rhodes, K. M., Schutz, K. C., Falls, W. A., Braas, K. M., & May,
V. (2009). Chronic stress increases pituitary adenylate cyclase-activating peptide
(PACAP) and brain-derived neurotrophic factor (BDNF) mRNA expression in the bed
nucleus of the stria terminalis (BNST): roles for PACAP in anxiety-like behavior.
Psychoneuroendocrinology, 34(6), 833-843. doi:10.1016/j.psyneuen.2008.12.013
Hannibal, J. (2002). Pituitary adenylate cyclase-activating peptide in the rat central nervous
system: an immunohistochemical and in situ hybridization study. J Comp Neurol, 453(4),
389-417. doi:10.1002/cne.10418
Hannibal, J., Hindersson, P., Knudsen, S. M., Georg, B., & Fahrenkrug, J. (2002). The
photopigment melanopsin is exclusively present in pituitary adenylate cyclase-activating
polypeptide-containing retinal ganglion cells of the retinohypothalamic tract. Journal of
Neuroscience, 22(1).

PACAP EXPRESSION IN AN AUDITORY NEUROCIRCUIT

17

Hannibal, J., Moller, M., Ottersen, O. P., & Fahrenkrug, J. (2000). PACAP and glutamate are costored in the retinohypothalamic tract. Journal of Comparative Neurology, 418(2), 147155.
Harmar, A. J., Arimura, A., Gozes, I., Journot, L., Laburthe, M., Pisegna, J. R., . . . Waschek, J.
A. (1998). International Union of Pharmacology. XVIII. Nomenclature of receptors for
vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide.
Pharmacological Reviews, 50(2), 265-270.
Harmar, A. J., Fahrenkrug, J., Gozes, I., Laburthe, M., May, V., Pisegna, J. R., . . . Said, S. I.
(2012). Pharmacology and functions of receptors for vasoactive intestinal peptide and
pituitary adenylate cyclase-activating polypeptide: IUPHAR review 1. Br J Pharmacol,
166(1), 4-17. doi:10.1111/j.1476-5381.2012.01871.x
Hosoya, M., Kimura, C., Ogi, K., Ohkubo, S., Miyamoto, Y., Kugoh, H., . . . et al. (1992).
Structure of the human pituitary adenylate cyclase activating polypeptide (PACAP) gene.
Biochim Biophys Acta, 1129(2), 199-206.
Howard, I. P., & Templeton, W. B. (1966). Human spatial orientation
Huang, J., Waters, K. A., & Machaalani, R. (2017). Pituitary adenylate cyclase activating
polypeptide (PACAP) and its receptor 1 (PAC1) in the human infant brain and changes in
the Sudden Infant Death Syndrome (SIDS). Neurobiology of Disease, 103, 70-77.
doi:10.1016/j.nbd.2017.04.002
Kawano, H., Shimozono, M., Tono, T., Miyata, A., & Komune, S. (2001). Expression of
pituitary adenylate cyclase-activating polypeptide mRNA in the cochlea of rats. Brain
Res Mol Brain Res, 94(1-2), 200-203.

PACAP EXPRESSION IN AN AUDITORY NEUROCIRCUIT

18

Kayser, C., Petkov, C. I., & Logothetis, N. K. (2008). Visual modulation of neurons in auditory
cortex. Cerebral Cortex, 18(7), 1560-1574. doi:10.1093/cercor/bhm187
Kimura, A., Donishi, T., Sakoda, T., Hazama, M., & Tamai, Y. (2003). Auditory thalamic nuclei
projections to the temporal cortex in the rat. Neuroscience, 117(4), 1003-1016.
doi:10.1016/S0306-4522(02)00949-1
Kondo, T., Tominaga, T., Ichikawa, M., & Iijima, T. (1997). Differential alteration of
hippocampal synaptic strength induced by pituitary adenylate cyclase activating
polypeptide-38 (PACAP-38). Neurosci Lett, 221(2-3), 189-192.
Krashes, M. J., Shah, B. P., Madara, J. C., Olson, D. P., Strochlic, D. E., Garfield, A. S., . . .
Lowell, B. B. (2014). An excitatory paraventricular nucleus to AgRP neuron circuit that
drives hunger. Nature, 507(7491), 238-+. doi:10.1038/nature12956
Laburthe, M., Couvineau, A., Gaudin, P., Maoret, J. J., RouyerFessard, C., & Nicole, P. (1996).
Receptors for VIP, PACAP, secretin, GRF, glucagon, GLP-1 and other members of their
new family of G protein-linked receptors: Structure-function relationship with special
reference to the human VIP-1 receptor. Vip, Pacap, and Related Peptides, 2nd
International Symposium, 805, 94-111.
Laburthe, M., Couvineau, A., & Tan, V. (2007). Class II G protein-coupled receptors for VIP
and PACAP: Structure, models of activation and pharmacology. Peptides, 28(9), 16311639. doi:10.1016/j.peptides.2007.04.026
Linke, R. (1999). Differential projection patterns of superior and inferior collicular neurons onto
posterior paralaminar nuclei of the thalamus surrounding the medial geniculate body in
the rat. European Journal of Neuroscience, 11(1), 187-203. doi:DOI 10.1046/j.14609568.1999.00422.x

PACAP EXPRESSION IN AN AUDITORY NEUROCIRCUIT

19

Llansola, M., Sanchez-Perez, A. M., Montoliu, C., & Felipo, V. (2004). Modulation of NMDA
receptor function by cyclic AMP in cerebellar neurones in culture. J Neurochem, 91(3),
591-599. doi:10.1111/j.1471-4159.2004.02730.x
Loe, P. R., & Benevento, L. A. (1969). Auditory-visual interaction in single units in the orbitoinsular cortex of the cat. Electroencephalogr Clin Neurophysiol, 26(4), 395-398.
Macdonald, D. S., Weerapura, M., Beazely, M. A., Martin, L., Czerwinski, W., Roder, J. C., . . .
MacDonald, J. F. (2005). Modulation of NMDA receptors by pituitary adenylate cyclase
activating peptide in CA1 neurons requires G alpha(q,) protein kinase C, and activation
of Src. Journal of Neuroscience, 25(49), 11374-11384. doi:10.1523/Jneurosci.387105.2005
Mellott, J. G., Bickford, M. E., & Schofield, B. R. (2014). Descending projections from auditory
cortex to excitatory and inhibitory cells in the nucleus of the brachium of the inferior
colliculus. Front Syst Neurosci, 8, 188. doi:10.3389/fnsys.2014.00188
Michel, S., Itri, J., Han, J. H., Gniotczynski, K., & Colwell, C. S. (2006). Regulation of
glutamatergic signalling by PACAP in the mammalian suprachiasmatic nucleus. BMC
Neurosci, 7, 15. doi:10.1186/1471-2202-7-15
Miyata, A., Arimura, A., Dahl, R. R., Minamino, N., Uehara, A., Jiang, L., . . . Coy, D. H.
(1989). Isolation of a Novel-38 Residue-Hypothalamic Polypeptide Which Stimulates
Adenylate-Cyclase in Pituitary-Cells. Biochemical and Biophysical Research
Communications, 164(1), 567-574. doi:Doi 10.1016/0006-291x(89)91757-9
Neylon, L., & Haight, J. R. (1983). Neocortical projections of the suprageniculate and posterior
thalamic nuclei in the marsupial brush-tailed possum, Trichosurus vulpecula
(Phalangeridae), with a comparative commentary on the organization of the posterior

PACAP EXPRESSION IN AN AUDITORY NEUROCIRCUIT

20

thalamus in marsupial and placental mammals. J Comp Neurol, 217(4), 357-375.
doi:10.1002/cne.902170402
Otto, C., Zuschratter, W., Gass, P., & Schutz, G. (1999). Presynaptic localization of the PACAPtypeI-receptor in hippocampal and cerebellar mossy fibres. Brain Res Mol Brain Res,
66(1-2), 163-174.
Paroczy, Z., Nagy, A., Markus, Z., Waleszczyk, W. J., Wypych, M., & Benedek, G. (2006).
Spatial and temporal visual properties of single neurons in the suprageniculate nucleus of
the thalamus. Neuroscience, 137(4), 1397-1404. doi:10.1016/j.neuroscience.2005.10.068
Recanzone, G. H. (2003). Auditory influences on visual temporal rate perception. J
Neurophysiol, 89(2), 1078-1093. doi:10.1152/jn.00706.2002
Roberto, M., & Brunelli, M. (2000). PACAP-38 enhances excitatory synaptic transmission in the
rat hippocampal CA1 region. Learn Mem, 7(5), 303-311.
Roberto, M., Scuri, R., & Brunelli, M. (2001). Differential effects of PACAP-38 on synaptic
responses in rat hippocampal CA1 region. Learn Mem, 8(5), 265-271.
doi:10.1101/lm.40501
Sherwood, N. M., Krueckl, S. L., & McRory, J. E. (2000). The origin and function of the
pituitary adenylate cyclase-activating polypeptide (PACAP)/glucagon superfamily.
Endocrine Reviews, 21(6), 619-670. doi:DOI 10.1210/er.21.6.619
Smith, P. H., Manning, K. A., & Uhlrich, D. J. (2010). Evaluation of inputs to rat primary
auditory cortex from the suprageniculate nucleus and extrastriate visual cortex. J Comp
Neurol, 518(18), 3679-3700. doi:10.1002/cne.22411

PACAP EXPRESSION IN AN AUDITORY NEUROCIRCUIT

21

Smith, P. H., Uhlrich, D. J., Manning, K. A., & Banks, M. I. (2012). Thalamocortical projections
to rat auditory cortex from the ventral and dorsal divisions of the medial geniculate
nucleus. J Comp Neurol, 520(1), 34-51. doi:10.1002/cne.22682
Stella, N., & Magistretti, P. J. (1996). Vasoactive intestinal peptide (VIP) and pituitary adenylate
cyclase-activating polypeptide (PACAP) potentiate the glutamate-evoked release of
arachidonic acid from mouse cortical neurons. Evidence for a cAMP-independent
mechanism. J Biol Chem, 271(39), 23705-23710.
Sudakov, K., MacLean, P. D., Reeves, A., & Marino, R. (1971). Unit study of exteroceptive
inputs to claustrocortex in awake, sitting, squirrel monkey. Brain Res, 28(1), 19-34.
Toda, A. M., & Huganir, R. L. (2015). Regulation of AMPA receptor phosphorylation by the
neuropeptide PACAP38. Proc Natl Acad Sci U S A, 112(21), 6712-6717.
doi:10.1073/pnas.1507229112
Vaudry, D., Falluel-Morel, A., Bourgault, S., Basille, M., Burel, D., Wurtz, O., . . . Vaudry, H.
(2009). Pituitary Adenylate Cyclase-Activating Polypeptide and Its Receptors: 20 Years
after the Discovery. Pharmacological Reviews, 61(3), 283-357.
doi:10.1124/pr.109.001370
Webster, D. B., & Fay, R. R. (Eds.). (2013). The mammalian auditory pathway:
neuroanatomy (Vol. 1). Springer Science & Business Media.
Yaka, R., He, D. Y., Phamluong, K., & Ron, D. (2003). Pituitary adenylate cyclase-activating
polypeptide (PACAP(1-38)) enhances N-methyl-D-aspartate receptor function and brainderived neurotrophic factor expression via RACK1. J Biol Chem, 278(11), 9630-9638.
doi:10.1074/jbc.M209141200

PACAP EXPRESSION IN AN AUDITORY NEUROCIRCUIT
Figures

Figure 1: Parasagittal view of the bat brain with lemniscal pathway (white) and extralemniscal
pathway (black). CN, cochlear nucleus; SC, superior colliculus; SG, suprageniculate nucleus.
Adapted from Casseday et al., (1989).
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Figure 2: Cre-induced mCherry expression in PACAP containing cells of the suprageniculate
thalamic nucleus. Observed with Cy3 or Texas Red filter sets. Right panel shows increased
magnification of left panel results.
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Figure 3: Allen Brain Atlas depiction of the expression of PACAP mRNA transcripts in the
suprageniculate thalamic nucleus of the mouse brain. Dotted circle emphasizes the observed
region: the suprageniculate thalamic nucleus.
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Figure 4: Allen Brain Atlas in situ hybridization for VGLUT1, VGLUT2, and GAD mRNA
transcripts in the mouse brain. Dotted circle emphasizes the region of observation: the
suprageniculate thalamic nucleus.
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